IROC Fees and Costs — Invesco Rochester High Yield Municipal ETF

Data updated: 2026-09-29

The net expense ratio is 0.39% (0.40% before fee waivers). There are no sales loads or redemption fees. Portfolio turnover was 52%.

IROC Fees and Expenses

Annual operating expenses and sales charges of IROC. Prospectus, as of February 28, 2026.

Annual operating expenses
Management fee0.39%
12b-1 fee—
Other expenses0.00%
Gross expense ratio0.40%
Fee waiver−0.01%
Net expense ratio0.39%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentNo

IROC Costs Over Time

On $10,000 invested in IROC, assuming 5% a year before costs, total costs come to $247 over 5 years, cutting the return by 0.41% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.39%)$41$129$224
Lost growth on money paid in costs$0$6$23
Total costs$41$135$247
Value after costs$10,459$11,441$12,516
Impact on return, per year0.41%0.41%0.41%

IROC Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2025.

  • Explicit cost rate (commissions ÷ average net assets): —
  • Total broker commissions: —
  • Bought from dealers (principal trades, not a cost): $134.5M
  • Portfolio turnover (prospectus): 52%
  • Securities lending: none during the year

IROC Dealer Counterparties

Securities bought directly from dealers (principal trades).

BrokerAmountShare
BNY MELLON CAPITAL MARKETS, LLC$62.5M52.76%
MORGAN STANLEY & CO. LLC$32.1M27.15%
RBC CAPITAL MARKETS, LLC$4.8M4.04%
PIPER JAFFRAY & CO.$4.0M3.36%
B. C. ZIEGLER AND CO.$3.2M2.74%
MERRILL LYNCH, PIERCE, FENNER & SMITH INC.$2.8M2.36%
WELLS FARGO SECURITIES, LLC$2.5M2.14%
HERBERT J. SIMS & CO, INC$2.5M2.08%
RAYMOND JAMES & ASSOCIATES, INC.$2.2M1.90%
TD SECURITIES (USA) LLC$1.8M1.48%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.